BRIEF-Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine

BRIEF-Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine
  • Country:
  • Angola

Pfizer Inc: * PFIZER SAYS CO, BIONTECH TO CO-DEVELOP POTENTIAL COVID-19 VACCINE

* PFIZER SAYS COS AGREED TO A LETTER OF INTENT REGARDING DISTRIBUTION (EXCLUDING CHINA) OF POTENTIAL MRNA-BASED CORONAVIRUS VACCINE * PFIZER SAYS COS WILL JOINTLY DEVELOP BIONTECH’S MRNA-BASED VACCINE CANDIDATE BNT162 TO PREVENT COVID-19 INFECTION Source text for Eikon:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.